|
ZBTB8A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.814400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.239000E-01 |
| Normal-vs-Stage2 |
1.553420E-01 |
| Normal-vs-Stage3 |
1.184630E-01 |
| Normal-vs-Stage4 |
1.216290E-02 |
| Stage1-vs-Stage2 |
3.323200E-01 |
| Stage1-vs-Stage3 |
3.239200E-01 |
| Stage1-vs-Stage4 |
1.731550E-01 |
| Stage2-vs-Stage3 |
9.048000E-01 |
| Stage2-vs-Stage4 |
5.112000E-01 |
| Stage3-vs-Stage4 |
4.076000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.604200E-01 |
| Normal-vs-AfricanAmerican |
2.107600E-01 |
| Normal-vs-Asian |
2.20659999999873E-05 |
| Caucasian-vs-AfricanAmerican |
5.341200E-01 |
| Caucasian-vs-Asian |
4.11300000000558E-05 |
| AfricanAmerican-vs-Asian |
1.260880E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.441760E-01 |
| Normal-vs-Female |
5.521800E-01 |
| Male-vs-Female |
8.384300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.228400E-01 |
| Normal-vs-Extreme_Weight |
2.090400E-01 |
| Normal-vs-Obese |
8.751000E-01 |
| Normal-vs-Extreme_Obese |
1.580380E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.523800E-01 |
| Normal_Weight-vs-Obese |
1.591580E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.400800E-01 |
| Extreme_Weight-vs-Obese |
2.334800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.070600E-01 |
| Obese-vs-Extreme_Obese |
3.681600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.569000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.162600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.450500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.834500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.589000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.224810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.446500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.216700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.745600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.193200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.221800E-01 |
| Normal-VS-Type2 PRCC |
3.80620000000054E-05 |
| Normal-VS-KIRP CIMP |
4.201000E-01 |
| Normal-VS-Unclassified PRCC |
9.938200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.27720000026233E-08 |
| Type1 PRCC-VS-KIRP CIMP |
5.898600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.497800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.154900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.256600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.763400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.792300E-04 |
| Normal-vs-N1 |
5.848200E-01 |
| Normal-vs-N2 |
1.098370E-02 |
| N0-vs-N1 |
1.101390E-01 |
| N0-vs-N2 |
3.485800E-01 |
| N1-vs-N2 |
2.004400E-01 |
|
|
